SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-096021
Filing Date
2022-08-30
Accepted
2022-08-30 16:05:33
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B3 tm2223490-6_424b3.htm 424B3 464484
2 GRAPHIC lg_addextherapeutics-4c.jpg GRAPHIC 22590
3 GRAPHIC tm2223490d1-fc_exdev4clr.jpg GRAPHIC 77057
4 GRAPHIC tm2223490d1-fc_indev4clr.jpg GRAPHIC 82400
5 GRAPHIC tm2223490d1-fc_matint4clr.jpg GRAPHIC 161596
6 GRAPHIC tm2223490d1-fc_erlystg4clr.jpg GRAPHIC 122267
  Complete submission text file 0001104659-22-096021.txt   1107938
Mailing Address CHEMIN DES MINES 9 GENEVA V8 CH-1202
Business Address CHEMIN DES MINES 9 GENEVA V8 CH-1202 01141228841555
Addex Therapeutics Ltd. (Filer) CIK: 0001574232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-266995 | Film No.: 221214551
SIC: 2834 Pharmaceutical Preparations